Gossamer Bio, Inc. (GOSS)
2.86
+0.12
(+4.38%)
USD |
NASDAQ |
Jan 22, 16:00
2.86
0.00 (0.00%)
After-Hours: 16:07
Gossamer Bio Cash from Investing (Quarterly): 17.01M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -207.00M |
| XOMA Royalty Corp. | 58.21M |
| Rezolute, Inc. | -68.49M |
| Axsome Therapeutics, Inc. | -0.058M |
| Crinetics Pharmaceuticals, Inc. | 164.81M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -36.17M |
| Cash from Financing (Quarterly) | 1.872M |
| Free Cash Flow | -158.51M |
| Free Cash Flow Per Share (Quarterly) | -0.1586 |
| Free Cash Flow to Equity (Quarterly) | -36.21M |
| Free Cash Flow to Firm (Quarterly) | -33.42M |
| Free Cash Flow Yield | -24.40% |